Quarterly report pursuant to sections 13 or 15(d)

Private Placement (Tables)

v2.4.0.8
Private Placement (Tables)
3 Months Ended
Mar. 31, 2014
Private Placement [Line Items]  
Convertible Debt [Table Text Block]
The debt discount is being amortized under the effective interest method over the term of the Convertible Notes. 
 
Face value of the Convertible Notes
 
$
5,500,009
 
Discount-fair value of embedded conversion feature
 
 
(5,376,000)
 
Proceeds attributable to the Convertible Notes
 
$
124,009
 
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]
Significant increases in either the probability or severity of default of the host instrument would result in a significantly lower fair value measurement. 
 
 
 
As of
March 31, 2014
 
 
As of
December 31, 2013
 
Stock price on valuation date
 
$
14.75
 
 
$
1.68
 
Conversion price
 
$
3.00
 
 
$
2.07
 
Term (years)
 
 
0.10
 
 
 
.26
 
Expected volatility
 
 
60
%
 
 
60
%
Dividend yield
 
 
0
%
 
 
0
%
Weighted average risk-free interest rate
 
 
1.32
%
 
 
1.75
%
Trials
 
 
20,000
 
 
 
20,000
 
Aggregate fair value
 
$
28,459,000
 
 
$
5,573,000
 
Financing And Consulting Warrant [Member]
 
Private Placement [Line Items]  
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]
Provided below are the principal assumptions used in the measurement of the fair values of the Financing Warrant and the Consulting Warrant as of March 31, 2014 and December 31, 2013.
 
 
 
As of March 31, 2014
 
 
As of December 31, 2013
 
 
 
Financing
Warrant
 
 
Consulting
Warrant
 
 
Financing
Warrant
 
 
Consulting
Warrant
 
Stock price on valuation date
 
$
14.75
 
 
$
14.75
 
 
$
1.68
 
 
$
1.68
 
Exercise price
 
$
3.60
 
 
$
0.04
 
 
$
2.49
 
 
$
0.04
 
Term (years)
 
 
4.13
 
 
 
4.13
 
 
 
4.38
 
 
 
4.38
 
Expected volatility
 
 
60
%
 
 
60
%
 
 
60
%
 
 
60
%
Dividend yield
 
 
0
%
 
 
0
%
 
 
0
%
 
 
0
%
Weighted average risk-free interest rate
 
 
1.32
%
 
 
1.32
%
 
 
1.75
%
 
 
1.75
%
Number of warrants
 
 
152,778
 
 
 
278,228
 
 
 
220,905
 
 
 
278,228
 
Number of trials
 
 
20,000
 
 
 
20,000
 
 
 
20,000
 
 
 
20,000
 
Aggregate fair value
 
$
1,764,000
 
 
$
4,045,000
 
 
$
175,000
 
 
$
529,000